Thieler Law Corp, member of the Investor Attorney Network, is investigating whether members of the board of directors of Chemtura Corporation (NYSE: CHMT) acted responsibly on behalf of investors’ profitability in the planned $2.5 billion sale to LANXESS AG.

On September 25, 2016, Chemtura Corporation (NYSE: CHMT) and LANXESS AG announced that they had entered into a merger agreement. Under the terms of the merger agreement, LANXESS will offer Chemtura shareholders $33.50 per share in cash for all outstanding shares.    

Based in Philadelphia, Pennsylvania, and founded in 1900 Chemtura Corporation develops, manufactures, and markets performance-driven engineered industrial specialty chemicals for industrial manufacturing customers.

The investigation is looking to uncover whether Chemtura Corporation was undervalued at the cost of the shareholders considering one analyst’s opinion of their stock is valued at $35.00 per share.

If you purchased Chemtura Corporation (NYSE: CHMT) prior to September 25, 2016, you should contact Thieler Law Corp at mail@thielerlaw.com or call +1 (619) 377 - 4324.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com 

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/ 

or

Facsimile: +1 (619) 785 – 3185